FAITH - Factor XA Inhibitor-Related InTracranial Haemorrhage

Trial Identifier:	D9603R00022
Sponsor:	AstraZeneca
NCTID::	NCT06420011
Start Date:	July 2024
Primary Completion Date:	November 2024
Study Completion Date:	November 2024

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

No locations posted.

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.